Cargando…
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer
Mounting evidence indicates that vitamin C has the potential to be a potent anti-cancer agent when administered intravenously and in high doses (high-dose IVC). Early phase clinical trials have confirmed safety and indicated efficacy of IVC in eradicating tumour cells of various cancer types. In rec...
Autores principales: | Böttger, Franziska, Vallés-Martí, Andrea, Cahn, Loraine, Jimenez, Connie R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557029/ https://www.ncbi.nlm.nih.gov/pubmed/34717701 http://dx.doi.org/10.1186/s13046-021-02134-y |
Ejemplares similares
-
Effect of high-dose intravenous vitamin C on inflammation in cancer patients
por: Mikirova, Nina, et al.
Publicado: (2012) -
Vitamin D as a promising anticancer agent
por: Chakraborti, Chandra Kanti
Publicado: (2011) -
Making sense of early high-dose intravenous vitamin C in ischemia/reperfusion injury
por: Spoelstra-de Man, Angelique M. E., et al.
Publicado: (2018) -
Potential benefit of high-dose intravenous vitamin C for coronavirus disease 2019 pneumonia
por: Zhao, Bing, et al.
Publicado: (2022) -
High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019
por: Xia, Guozhi, et al.
Publicado: (2021)